Funding for this research was provided by:
National Cancer Institute (CA205247, CA248475)
Received: 29 April 2021
Accepted: 31 July 2021
First Online: 9 August 2021
: Patient sample acquisition was approved by the Institutional Review Boards (IRB) at the COHNMC, in accordance with an assurance filed with and approved by the Department of Health and Human Services and met all requirements of the Declaration of Helsinki. CML patients were consented on the IRB #18067 protocol.
: Not applicable.
: The authors declare that they have no competing interests.